🇺🇸 FDA
Pipeline program

Combination Cinacalcet with Vitamin D analogue

CT14-HPP-004

Approved small_molecule active

Quick answer

Combination Cinacalcet with Vitamin D analogue for Secondary Hyperparathyroidism is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Secondary Hyperparathyroidism
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials